122 related articles for article (PubMed ID: 19332867)
1. Acute nephritic syndrome after anti-VEGF therapy for renal cell carcinoma.
Rolleman EJ; Weening J; Betjes MG
Nephrol Dial Transplant; 2009 Jun; 24(6):2002-3. PubMed ID: 19332867
[No Abstract] [Full Text] [Related]
2. All anti-vascular endothelial growth factor drugs can induce 'pre-eclampsia-like syndrome': a RARe study.
Vigneau C; Lorcy N; Dolley-Hitze T; Jouan F; Arlot-Bonnemains Y; Laguerre B; Verhoest G; Goujon JM; Belaud-Rotureau MA; Rioux-Leclercq N
Nephrol Dial Transplant; 2014 Feb; 29(2):325-32. PubMed ID: 24302609
[TBL] [Abstract][Full Text] [Related]
3. Acute cardiac failure after sunitinib.
Machiels JP; Bletard N; Pirenne P; Jacquet L; Bonbled F; Duck L
Ann Oncol; 2008 Mar; 19(3):597-9. PubMed ID: 18272908
[No Abstract] [Full Text] [Related]
4. Uncommon side effect with a commonly used targeted agent: sunitinib-induced nephrotic syndrome in a patient with metastatic renal cell carcinoma.
Quintyne KI; Neenan T; Casserly L; Gupta R
BMJ Case Rep; 2014 May; 2014():. PubMed ID: 24872478
[TBL] [Abstract][Full Text] [Related]
5. Biopsy-proven acute interstitial nephritis associated with the tyrosine kinase inhibitor sunitinib: a class effect?
Winn SK; Ellis S; Savage P; Sampson S; Marsh JE
Nephrol Dial Transplant; 2009 Feb; 24(2):673-5. PubMed ID: 19039026
[TBL] [Abstract][Full Text] [Related]
6. Pyoderma gangrenosum with the use of sunitinib.
Nadauld LD; Miller MB; Srinivas S
J Clin Oncol; 2011 Apr; 29(10):e266-7. PubMed ID: 21220606
[No Abstract] [Full Text] [Related]
7. Hand-foot syndrome and seborrheic dermatitis-like rash induced by sunitinib in a patient with advanced renal cell carcinoma.
Tsai KY; Yang CH; Kuo TT; Hong HS; Chang JW
J Clin Oncol; 2006 Dec; 24(36):5786-8. PubMed ID: 17179114
[No Abstract] [Full Text] [Related]
8. Skin depigmentation induced by sunitinib treatment of renal cell carcinoma.
Al Enazi MM; Kadry R; Mitwali H
J Am Acad Dermatol; 2009 Nov; 61(5):905-6. PubMed ID: 19836653
[No Abstract] [Full Text] [Related]
9. Reversible posterior leukoencephalopathy syndrome induced by sunitinib.
Martín G; Bellido L; Cruz JJ
J Clin Oncol; 2007 Aug; 25(23):3559. PubMed ID: 17687168
[No Abstract] [Full Text] [Related]
10. Cardiac tamponade in a patient treated by sunitinib for metastatic renal cell carcinoma.
Yıldız I; Varol U; Şen F; Kılıç L
Anadolu Kardiyol Derg; 2014 Nov; 14(7):654-6. PubMed ID: 25163084
[No Abstract] [Full Text] [Related]
11. Re: Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib.
Garfield DH; Hercbergs A; Davis PJ
J Natl Cancer Inst; 2007 Jun; 99(12):975-6; author reply 976-7. PubMed ID: 17565154
[No Abstract] [Full Text] [Related]
12. A case of pyoderma gangrenosum possibly associated with sunitinib treatment.
Ueharaguchi Y; Kabashima K; Sasahashi M; Matsuda A; Matubara K; Matsui M
Int J Dermatol; 2013 May; 52(5):634-6. PubMed ID: 23590380
[No Abstract] [Full Text] [Related]
13. Re: Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib.
Feldman DR; Martorella AJ; Robbins RJ; Motzer RJ
J Natl Cancer Inst; 2007 Jun; 99(12):974-5; author reply 976-7. PubMed ID: 17565156
[No Abstract] [Full Text] [Related]
14. Reversible myocardial dysfunction in a young woman with metastatic renal cell carcinoma treated with sunitinib.
Szmit S; Nurzyński P; Szaluś N; Opolski G; Szczylik C
Acta Oncol; 2009; 48(6):921-5. PubMed ID: 19191048
[No Abstract] [Full Text] [Related]
15. Vascular endothelial growth factor-targeted therapy in renal cell carcinoma: current status and future directions.
Rini BI
Clin Cancer Res; 2007 Feb; 13(4):1098-106. PubMed ID: 17317817
[TBL] [Abstract][Full Text] [Related]
16. Response to 'Thyrotoxicosis during sunitinib treatment for renal cell carcinoma' by Grossmann et al.
Daniels GH
Clin Endocrinol (Oxf); 2009 Sep; 71(3):455. PubMed ID: 19138312
[No Abstract] [Full Text] [Related]
17. Psychotic symptoms in the course of sunitinib treatment for advanced renal cell cancer. Two cases.
Schellekens AF; Mulder SF; van Eijndhoven PF; Smilde TJ; van Herpen CM
Gen Hosp Psychiatry; 2011; 33(1):83.e1-3. PubMed ID: 21353137
[No Abstract] [Full Text] [Related]
18. Sunitinib-aggravated hypertension.
Rivera F; Benounna M; Sánchez de la Nieta MD
J Hypertens; 2009 Jul; 27(7):1502-3. PubMed ID: 19542988
[No Abstract] [Full Text] [Related]
19. Sunitinib-induced hand-foot syndrome in a renal cell carcinoma: a sclerodermatous and rheumatoid arthritis-like case.
Ohtsuka T
J Dermatol; 2012 Nov; 39(11):943-4. PubMed ID: 22257303
[No Abstract] [Full Text] [Related]
20. Efficacy and toxicity of sunitinib in patients with metastatic renal cell carcinoma with severe renal impairment or on haemodialysis.
O'Donnell PH
BJU Int; 2011 Oct; 108(8):1284-5. PubMed ID: 21418138
[No Abstract] [Full Text] [Related]
[Next] [New Search]